Label-Free Impedance Cytometry for Apoptotic Body Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for detecting and quantifying apoptotic bodies (ABs) in cancer cell cultures are limited by their sensitivity, specificity, and ability to differentiate ABs from other cellular matter, such as exosomes and debris, which complicates the assessment of drug sensitivity and resistance.
Innovation Solution
Utilizing frequency-modulated, electrically driven microfluidic measurement and separation techniques to detect and quantify ABs based on their electrical properties, such as impedance, allowing for single-cell sensitivity and real-time differentiation between AB subpopulations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If fluorescence imaging is used to detect apoptotic bodies, then biological markers can be identified, but sensitivity is reduced and ability to identify certain types of biological markers is limited
Solution Approach 1:
The patent extracts the fluorescent labels from the detection system and replaces them with label-free impedance measurement. By removing the labeling step entirely, the system achieves higher sensitivity without the complexity of probe selection, optimization, and potential interference with natural biological processes.
Solution Approach 2:
The patent substitutes the optical detection mechanism (fluorescence imaging) with an electrical measurement mechanism (impedance cytometry). This replacement eliminates the need for fluorescent probes while providing enhanced sensitivity and the ability to detect a broader range of biological markers through electrical property measurements.
2Measurement precision
If flow cytometry is used to detect apoptotic bodies, then quantification can be performed, but sensitivity and specificity are limited
Solution Approach 1:
The impedance cytometry system performs multiple detection functions simultaneously - measuring size, membrane integrity, internal structure, and electrical properties of apoptotic bodies in a single pass. This multi-functionality increases both sensitivity and the amount of information obtained per sample without requiring multiple separate assays.
3Measurement precision
If traditional methods are used to differentiate apoptotic bodies from other cellular matter, then detection can be performed, but specificity is reduced
Solution Approach 1:
The patent adds electrical impedance as a new dimension of measurement beyond traditional size-based differentiation. By measuring multiple impedance parameters (magnitude, phase, frequency response), the system creates a multidimensional characterization of apoptotic bodies that enables highly specific differentiation from exosomes and cellular debris without increasing operational complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate differentiation of ABs from other cellular material and provides real-time information on drug sensitivity and resistance, facilitating improved drug treatment planning for cancer cells.
Implementation Method 1
triggering generation of an alternating current (AC) electrical stimulus to a set of electrode structures that are electrically coupled with the flow cell structure for impedance measurement of flowing secreted bodies
Data Source
AI summary
A microfluidic system can be used to quantify apoptotic bodies (ABs) with single-cell sensitivity, providing real-time information regarding the presence, and properties of ABs. Different subpopulations of ABs can thus be distinguished from one another to quantify cellular dis-assembly and drug sensitivity of the cancer cells under test. Impedance measurement can be performed by flowing secreted bodies at a substantially single-particle sensitivity. A plurality of electrical impedance magnitude and phase parameters of the biological sample can be measured within the flow cell structure, corresponding to a specified range of frequencies to help determine a biological characteristic of the cancer cells.